@oncogenejournal@Timofey_LTD@Elya_Elmira_Mi Great to see our paper published! Sorry, but the wrong person is tagged (@elmira_vagapova is the correct account of our lab member)
Our paper on growth factor signaling in #neuroblastoma is provisionally accepted for publication in @oncogenejournal@Timofey_LTD
@elmira_vagapova
We will share more details soon 🔜
#EHA2021#abstracts now online: https://t.co/YOMo4S6AQb
🗨️ Abstracts will be presented orally in the Presidential Symposium, Oral Sessions, & as e-posters, and as a publication 📚 in the digital abstract book.
🔎 Browse the abstracts and select the presentations you want to see!
We are organizing Special Issue "Retroviruses and Retroviral, Lentiviral Vectors in Modern Biology" in @MDPIOpenAccess@IJMS_MDPI
Special Issue Editor
Prof. Dr. Vladimir S. Prassolov - Head of the Cancer Cell Biology Department (our lab)
Welcome with your submissions!
Immunoproteasome Activity and Content Determine Hematopoietic Cell Sensitivity to ONX‐0914 and to the Infection of Cells with Lentiviruses - our fresh paper in collaboration with Alexei Morozov
Well done @elmira__mi and @Timofey_LTD 🎈
@Cells_MDPI
https://t.co/wdWwIVQBLb
Our lab members @elmira__mi and @Timofei_LTD attending #PISA2020 with ePosters right now 👍 @ASIPath
Interested in ERK signaling, kinase inhibitors resistance or novel therapeutic approaches in neuroblastoma and myeloid leukemia? Check A010 and A011.
#NTRK1 and #KIT isoforms in #leukemia and #neuroblastoma. NGF and SCF rescue leukemia and neuroblastoma cells from doxorubicin and cytarabine induced death.
New research: Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia: Pediatric cancers represent a wide variety of different tumors, though they have unique… https://t.co/iVXzXsfp4g #oncology